We are live on ! Find out more
IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
1-Year Est. Return 48.5%
This Fund
S&P 500
This Quarter Est. Return
-5.38%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
–
AUM
$237M
AUM Growth
-$617K
Cap. Flow
+$28M
Cap. Flow %
11.84%
Top 10 Hldgs %
98.84%
Holding
12
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
STIM icon
Neuronetics
STIM
+$28M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$89.9M 37.98%
2,021,738
– –
GKOS icon
2
Glaukos
GKOS
$8.92B
$41.4M 17.48%
1,018,362
– –
STIM icon
3
Neuronetics
STIM
$126M
$27.4M 11.58%
+1,030,689
New +$28M
MGNX icon
4
MacroGenics
MGNX
$254M
$22.2M 9.37%
1,074,316
– –
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$19.5M 8.24%
53,320
– –
VERO
6
DELISTED
Venus Concept
VERO
$11.6M 4.92%
1,356
– –
CDTX
7
DELISTED
Cidara Therapeutics
CDTX
$7.05M 2.98%
67,841
– –
AGTC
8
DELISTED
Applied Genetic Technologies Corporation
AGTC
$5.39M 2.28%
1,455,904
– –
HIND
9
Vyome Holdings
HIND
$14M
– –
0
– –
IVTY
10
DELISTED
Invuity, Inc
IVTY
$4.21M 1.78%
1,080,272
– –
KALV
11
DELISTED
KalVista Pharmaceuticals
KALV
$2.68M 1.13%
329,942
– –
XENE icon
12
Xenon Pharmaceuticals
XENE
$6.36B
$76K 0.03%
8,293
– –

Similar funds

RCP
Rho Capital Partners New York $20.4M AUM
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

InterWest Venture Management's Q2 2018 Portfolio in Review

As of Q2 2018, InterWest Venture Management held 12 positions worth $237M, down 0.26% from $237M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

InterWest Venture Management deployed $28M of net new capital in Q2 2018, opening 1 new position. Its largest new stake was Neuronetics: 1,030,689 shares worth $27.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • InterWest Venture Management's largest Q2 2018 buy was Neuronetics: 1,030,689 shares worth $27.4M.
  • InterWest Venture Management's ten largest holdings make up 99% of its $237M portfolio in Q2 2018.
  • InterWest Venture Management opened 1 new position and closed 0 in Q2 2018.
  • InterWest Venture Management's portfolio value fell 0.26% quarter-over-quarter to $237M.

Based on InterWest Venture Management's 13F filing for Q2 2018, filed 5 Jul 2018.